362. Paul Coletta, Co-Founder & CEO of Vero Bioscience

Today, I'm joined by Paul Coletta, co-founder & CEO of Vero Bioscience.

A predictive health company, Vero uses proteomic blood tests and proprietary AI to measure and improve organ-level aging.

In this episode, we discuss building a closed-loop health system powered by proteomics.

We also cover:

Why organ-level data beats whole-body scores How proteomics differs from other biological age measures Reproducibility, clinical validation, and roadmap to launch

Subscribe to the podcast → insider.fitt.co/podcast

Subscribe to our newsletter → insider.fitt.co/subscribe

Follow us on LinkedIn → linkedin.com/company/fittinsider

Get on the waitlist: verobioscience.com

X (Twitter): https://x.com/Vero_Bioscience

Follow Paul: https://www.linkedin.com/in/paulcoletta

Follow Vero: https://www.linkedin.com/company/vero-bioscience-inc